Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought? (2021)

First Author: McBride A
Attributed to:  Experimental Medicine INitiative to Explore New Therapies - Phase 2 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(21)00087-2

PubMed Identifier: 33899037

Publication URI: http://europepmc.org/abstract/MED/33899037

Type: Journal Article/Review

Volume: 2

Parent Publication: The Lancet. Microbe

Issue: 7

ISSN: 2666-5247